No Data
No Data
Insider Sale: Chief Medical Officer of $RNA Sells 9,578 Shares
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TD Cowen Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $78
Avidity Biosciences' Promising Developments in DMD Treatment and Strategic Preparations for Future Success
Forecasting The Future: 13 Analyst Projections For Avidity Biosciences